Dr. Manish Kumar
Also known as: Dr. Manish Kumar
Cadila Pharmaceuticals (India), Indian Institute of Technology BHU Varanasi, Babasaheb Bhimrao Ambedkar University, Sardar Bhagwan Singh Post Graduate Institute of Biomedical Science and Research
0000-0002-0013-6552
About
Doctorate from Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India. Working on the design of advanced drug delivery systems for cancer, diabetes, wound, infection, and inflammatory disease management. Research interests include controlled drug delivery, nanoemulsions, polymeric nanoparticles, lipid nanoparticles, nanocrystals, nanofibrous scaffolds, hydrogels, microneedles and other pharmaceutical formulations. Working continuously to drive forward cutting-edge research in nanomedicine and drug delivery technologies.
Employment
-
Cadila Pharmaceuticals (India) Deputy Manager2025 - Present
Education
-
Indian Institute of Technology BHU Varanasi PhD2019 - 2024
-
Babasaheb Bhimrao Ambedkar University PhD2018 - 2019
-
Sardar Bhagwan Singh Post Graduate Institute of Biomedical Science and Research MPharm2016 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (30)
- Breaking barriers: nanosystems to overcome solubility and permeability challenges of second-generation tyrosine kinase inhibitors Save
- Unraveling the artificial intelligence role in drug discovery and pharmaceutical product design: an opportunity and challenges Save
- Fabrication of lipid-modified drug nanocrystals loaded injectable hydrogel for breast cancer therapy Save
- Formulation and Evaluation of Lipid/Soluplus-Stabilized Nanocrystals of Paclitaxel and Bosutinib for a Synergistic Effect in Non-Small Cell Lung Cancer Therapy Save
- Cabazitaxel-loaded redox-responsive nanocarrier based on d-alpha-tocopheryl-chitosan and hyaluronic acid for improved anti-tumor efficacy in DMBA-induced breast cancer model Save
- Heparin sodium enriched gelatin/polycaprolactone based multi-layer nanofibrous scaffold for accelerated wound healing in diabetes Save
- Fabrication of Dual Drug-Loaded Polycaprolactone–Gelatin Composite Nanofibers for Full Thickness Diabetic Wound Healing Save
- Formulation and characterization of polyvinyl alcohol/chitosan composite nanofiber co-loaded with silver nanoparticle & luliconazole encapsulated poly lactic-co-glycolic acid nanoparticle for treatment of diabetic foot ulcer Save
- Fabrication of gelatin coated polycaprolactone nanofiber scaffolds co-loaded with luliconazole and naringenin for treatment of Candida infected diabetic wounds Save
- Biopolymer-Based Tumor Microenvironment-Responsive Nanomedicine for Targeted Cancer Therapy Save